Describing themselves as a leading provider of next generation breast imaging detectors based on the firm's proprietary perovskite imaging sensors, Kairos Sensors is indicated by founder and senior management as focused on commercializing perovskite/graphene sensors for superior tissue discrimination for diagnostic accuracy with product development of multi-spectral photon counting detectors used in molecular CT imaging. At the core of what the firm about is lies inthe firm's progress towards Innovative, ultra-sensitive X-ray sensors for diagnostic imaging offering the clear option of being able to differentiat unhealthy tissue from healthy tissue. Itis noted that current state-of-the-art X-ray sensors lack grayscale sensitivity to differentiate similar density tissues. In that context, mammography technology used today in many hospitals and clinics cannot efficiently distinguish between healthy tissue and cancerous tissue. How can that be so? Currently, 3D-mammography detectors have a low signal-to-noise ratio because relatively few photons are incident per pixel for each image slice that make up the entire breast volume dataset. This means that the images produced are low quality with inadequate diagnostic information. In consequence, false positives/negatives are prevalent - creating the need for secondary screenings .e.e because sensor materials in these devices are not sensitive enough to determine cancerous tissue accurately. In contrast, the Kairos Sensor innovative detector uses perovskite-based materials to create a signal-to-noise ratio that is 100x higher than that that is capable in current mammography imaging. The firm's perovskite-based APeX⢠sensors are ultra-sensitive and are able to distinguish the difference in similar density materials. The combination of materials used by Kairos Sensors amplifies the readout signal per pixel which - inturn - results in higher contrast resolution in grayscale images. This important factor allows physicians to analyze images and be able better to determine potential unhealthy tissue in breast exams. Physicians having have access to this much more sensitive equipment offered by Kairos Sensors could mean a dramatic reduction inthe need for second screenings by patients.
